Prometrika
PROMETRIKA is a global, full-service clinical research organization (CRO) supporting the biopharmaceutical and medical device industries since 2003. Based in Cambridge, Massachusetts, PROMETRIKA offers comprehensive services including clinical operations, data management, biostatistics, medical writing, pharmacovigilance, and regulatory submissions. The company is driven by a passion for the human aspect of their work and a commitment to quality, integrity, and innovation, aiming to improve patient lives through innovative clinical solutions.
Industries
Nr. of Employees
medium (51-250)
Prometrika
Products
Full-Service
A turnkey clinical research organization solution providing sponsors with a single point of contact, consistent standard operating procedures, and expertise across clinical operations, data management, biostatistics, medical writing, and pharmacovigilance.
Full-Service CRO
Full-service clinical research organization services designed to improve efficiency, control costs, and increase profitability for sponsors.
Functional Service Provider
PROMETRIKA offers functional service provider (FSP) services in specific areas of expertise, including stand-alone clinical monitoring, data management, biostatistics, programming, medical writing, and regulatory services.
Functional Service Provider (FSP)
Functional service provider CRO services offering depth, experience, and flexibility to work with sponsors.
NDA & MAA
Comprehensive experience in New Drug Applications (NDAs), Biologics License Applications (BLAs), and Marketing Authorization Applications (MAAs) including specialized statistical analyses and expert medical writing.
NDA & MAA Submissions
Preparation and management of NDA, BLA, and MAA submissions for regulatory authorities.
Full-Service
A turnkey clinical research organization solution providing sponsors with a single point of contact, consistent standard operating procedures, and expertise across clinical operations, data management, biostatistics, medical writing, and pharmacovigilance.
Full-Service CRO
Full-service clinical research organization services designed to improve efficiency, control costs, and increase profitability for sponsors.
Functional Service Provider
PROMETRIKA offers functional service provider (FSP) services in specific areas of expertise, including stand-alone clinical monitoring, data management, biostatistics, programming, medical writing, and regulatory services.
Functional Service Provider (FSP)
Functional service provider CRO services offering depth, experience, and flexibility to work with sponsors.
NDA & MAA
Comprehensive experience in New Drug Applications (NDAs), Biologics License Applications (BLAs), and Marketing Authorization Applications (MAAs) including specialized statistical analyses and expert medical writing.
NDA & MAA Submissions
Preparation and management of NDA, BLA, and MAA submissions for regulatory authorities.
Services
Advisory services including clinical program planning, statistical consulting, regulatory affairs and operations, technology strategy, and infrastructure support.
End-to-end clinical development services covering pre-IND, IND enabling activities, Phase 1-3 trial execution, regulatory submission support (NDA/BLA/MAA), and Phase 4/post-marketing studies.
Stand-alone or integrated functional offerings including clinical operations, data management, biostatistics and programming, medical writing, and pharmacovigilance.
Protocol drafting, adaptive design planning, and statistical design services to support complex and efficient study designs.
Implementation of CDISC SDTM and ADaM standards, mapping of clinical datasets, and preparation of submission-ready datasets.
Design, configuration, and operation of cloud-based clinical trial platforms for EDC, RTSM/IWRS, ePRO, eConsent, wearable integrations, and data unification.
Advisory services including clinical program planning, statistical consulting, regulatory affairs and operations, technology strategy, and infrastructure support.
End-to-end clinical development services covering pre-IND, IND enabling activities, Phase 1-3 trial execution, regulatory submission support (NDA/BLA/MAA), and Phase 4/post-marketing studies.
Stand-alone or integrated functional offerings including clinical operations, data management, biostatistics and programming, medical writing, and pharmacovigilance.
Protocol drafting, adaptive design planning, and statistical design services to support complex and efficient study designs.
Implementation of CDISC SDTM and ADaM standards, mapping of clinical datasets, and preparation of submission-ready datasets.
Design, configuration, and operation of cloud-based clinical trial platforms for EDC, RTSM/IWRS, ePRO, eConsent, wearable integrations, and data unification.
Expertise Areas
- Clinical trial management (Phases I-IV)
- Rare disease clinical development
- Oncology clinical trials
- Biostatistics and statistical programming
Key Technologies
- CDISC SDTM
- CDISC ADaM
- Electronic Data Capture (EDC)
- Randomization and Trial Supply Management (RTSM/IWRS)
News & Updates
PROMETRIKA will attend the SCOPE 2024 conference in Orlando, FL, from February 11-14, 2024.
PROMETRIKA’s President and CEO, Dr. Miganush Stepanians, and Senior Biostatistical Standards and Implementation Specialist, Benny Chan, will participate in a panel discussion on innovative approaches for tackling complex trials at Medidata NEXT in New York on November 7, 2023.
PROMETRIKA sponsors the MassBio 2025 Rare Disease Day Forum on February 28, 2025, in Cambridge, MA, supporting the community involved in rare disease research and advocacy.
PROMETRIKA partnered with Medidata on a case study about strategies for success in complex trials and the advantages of the integrated RTSM platform over other IRT solutions.
PROMETRIKA has recently achieved accreditation on Medidata Rave Targeted SDV, enhancing data quality and regulatory compliance in clinical trials.
PROMETRIKA will attend the SCOPE 2024 conference in Orlando, FL, from February 11-14, 2024.
PROMETRIKA’s President and CEO, Dr. Miganush Stepanians, and Senior Biostatistical Standards and Implementation Specialist, Benny Chan, will participate in a panel discussion on innovative approaches for tackling complex trials at Medidata NEXT in New York on November 7, 2023.
PROMETRIKA sponsors the MassBio 2025 Rare Disease Day Forum on February 28, 2025, in Cambridge, MA, supporting the community involved in rare disease research and advocacy.
PROMETRIKA partnered with Medidata on a case study about strategies for success in complex trials and the advantages of the integrated RTSM platform over other IRT solutions.
PROMETRIKA has recently achieved accreditation on Medidata Rave Targeted SDV, enhancing data quality and regulatory compliance in clinical trials.